Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Ferumoxytol vs Iron Sucrose for Iron Deficiency Anemia
2010-018961-50Phase 3Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- May 2010
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferumoxytol in iron deficiency anemia (IDA) (2 arms), sponsored by AMAG Pharmaceuticals, Inc. Primary endpoint: Proportion of subjects with ≥2.0 g/dL hemoglobin increase. Started May 2010; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2010-018961-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018961-50.